SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 948.15 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 243.78K shares, a 96.61% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.19M shares, a 2107.24% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 325.54K shares, a 23.15% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 2.72M shares, a 13480.17% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 209.09K shares, a 36.38% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 328.67K shares, a 547.03% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 50.80K shares, a 65.11% decline from fiscal 2021.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 145.59K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 948.15K shares 10-Q · filed 2026-09-24 | |||||||
| 2026-03-31 | 243.78K shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 28.86K shares 10-Q · filed 2026-09-24 | 288.55K shares 10-K · filed 2026-03-31 | ||||||
| 2025-09-30 | 421.33K shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 279.99K shares 10-Q · filed 2025-08-13 | |||||||
| 2025-03-31 | 7.19M shares 10-Q · filed 2025-05-08 | |||||||
| 2024-12-31 | 209.09K shares 10-K · filed 2026-03-31 | 5.23M shares 10-K · filed 2025-02-26 | ||||||
| 2024-09-30 | 9.02K shares 10-Q · filed 2025-11-13 | 225.34K shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | 12.94K shares 10-Q · filed 2025-08-13 | 323.58K shares 10-Q · filed 2024-09-04 | ||||||
| 2024-03-31 | 325.54K shares 10-Q · filed 2025-05-08 | 2.58M shares 10-Q · filed 2024-05-13 | ||||||
| 2023-12-31 | 328.67K shares 10-K · filed 2025-02-26 | 2.60M shares 10-K · filed 2024-03-21 | ||||||
| 2023-09-30 | 2.72M shares 10-Q · filed 2023-11-13 | 342.74K shares 10-Q · filed 2024-11-13 | 2.72M shares 10-Q · filed 2023-11-13 | |||||
| 2023-06-30 | 349.76K shares 10-Q · filed 2024-09-04 | 2.77M shares 10-Q · filed 2023-08-14 | ||||||
| 2023-03-31 | 423.61K shares 10-Q/A · filed 2024-09-04 | 3.36M shares 10-Q · filed 2023-05-25 | ||||||
| 2022-12-31 | 50.80K shares 10-K/A · filed 2024-09-04 | 356.81K shares 10-K · filed 2023-03-15 | ||||||
| 2022-09-30 | 20.00K shares 10-Q · filed 2023-11-13 | 20.00K shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 145.59K shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 145.59K shares 10-Q · filed 2023-05-25 | |||||||
| 2021-12-31 | 145.59K shares 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |